๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-Dose-Rate Intraoperative Radiation Therapy for Pediatric Sarcoma: Outcomes, Toxicity, and Practice Recommendations

โœ Scribed by Tong, W.; Folkert, M.R.; LaQuaglia, M.P.; Wexler, L.H.; Meyers, P.A.; Zelefsky, M.J.; Wolden, S.L.

Book ID
122213928
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
61 KB
Volume
87
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High-dose rate intraoperative radiation
High-dose rate intraoperative radiation therapy for pediatric solid tumors
โœ Merchant, Thomas E.; Zelefsky, Michael J.; Sheldon, John M.; LaQuaglia, Michael ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 36 KB ๐Ÿ‘ 2 views

Background. Sixteen pediatric patients with solid tumors received treatment on a protocol designed to test the feasibility and safety of high-dose rate intraoperative radiation therapy (IOHDR) via a remote afterloader. Patients and Methods. Patients with Ewing's sarcoma (n = 5), rhabdomyosarcoma (n

Feasibility of intraoperative high-dose
Feasibility of intraoperative high-dose rate brachytherapy to boost low dose external beam radiation therapy to treat pediatric soft tissue sarcomas
โœ Nag, Subir; Martinez-Monge, Rafael; Ruymann, Frederick B.; Bauer, Constance J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 810 KB

## Purpose. To determine if a single intraoperative high-dose-rate brachytherapy (IOHDR) dose can be used in conjunction with low dose external beam radiation therapy (EBRT) to treat soft tissue malignancies in children with reduced morbidity. Methods. From March 1992 to February 1995, six pediatr

Preliminary results of Phase I/II study
Preliminary results of Phase I/II study of high-dose-rate intraoperative radiation therapy for pediatric tumors
โœ Zelefsky, Michael J.; Laquaglia, Michael P.; Ghavimi, Fereshteh; Bass, Joanne; H ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 536 KB

Ten children with locally advanced or recurrent tumors were treated on a Phase 1/11 study to assess the feasibility and toxicity of intraoperative radiotherapy (IORT) for primary and recurrent pediatric solid malignancies at high risk for local recurrence. Eligible patients include all primary and r